FDA Panel Votes to Recommend Pfizer Vaccine for Emergency Authorization
An FDA panel voted 17–4 to give emergency use authorization to the Pfizer vaccine.
A panel of advisers to the FDA voted on December 10 to recommend that Pfizer’s COVID-19 vaccine be given emergency use authorization, according to NPR.
The 17–4 vote decided that the benefits of the vaccine outnumbered the risks. On the heels of Britain’s approval of the vaccine, the FDA is expected to decide on emergency authorization for the United States soon.
The FDA’s analysis of the Pfizer vaccine was released on December 8. It contained documents that support the emergency authorization. It was determined during a pre-meeting analysis on December 4 that there were “no specific safety concerns identified that would preclude the issuance of an EUA.”
To read more about the FDA’s analysis of the Pfizer vaccine, visit fda.gov.